Compounds > puromycin aminonucleoside

puromycin aminonucleoside and probucol

puromycin aminonucleoside has been researched along with probucol in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hirano, T; Morohoshi, T	1
Hirano, T; Mamo, JC; Nagano, S; Sugisaki, T	1
Hirano, T; Mamo, JC; Ohnami, K; Sugisaki, T	1
Magil, A	1
Chung, HK; Jeong, JY; Kim, BC; Kim, YS; Lee, HS; Zhang, YZ	1
Drukker, A; Eddy, AA	1

Other Studies

6 other study(ies) available for puromycin aminonucleoside and probucol

Article	Year
Treatment of hyperlipidemia with probucol suppresses the development of focal and segmental glomerulosclerosis in chronic aminonucleoside nephrosis. Nephron, 1992, Volume: 60, Issue:4 Topics: Animals; Glomerulosclerosis, Focal Segmental; Hyperlipidemias; Male; Nephrotic Syndrome; Probucol; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains	1992
The lowering effect of probucol on plasma lipoprotein and proteinuria in puromycin aminonucleoside-induced nephrotic rats. Nephron, 1991, Volume: 58, Issue:1 Topics: Animals; Hyperlipidemias; Hyperlipoproteinemias; Kidney; Male; Nephrotic Syndrome; Organ Size; Probucol; Proteinuria; Puromycin Aminonucleoside; Rats	1991
Treatment of hyperlipidemia with probucol reduces proteinuria in puromycin aminonucleoside-induced nephrotic rats. Nephron, 1990, Volume: 54, Issue:4 Topics: Animals; Hyperlipidemias; Male; Nephrotic Syndrome; Phenols; Probucol; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains	1990
Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant. Journal of the American Society of Nephrology : JASN, 1996, Volume: 7, Issue:11 Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Chronic Disease; Disease Models, Animal; Disease Progression; Follow-Up Studies; Immunohistochemistry; Infusions, Intravenous; Kidney Glomerulus; Lipid Metabolism; Male; Nephrotic Syndrome; Probucol; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley	1996
Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis. Kidney international, 1997, Volume: 51, Issue:4 Topics: Animals; Anticholesteremic Agents; Antioxidants; Cholesterol, Dietary; Diet; Glomerulosclerosis, Focal Segmental; Hypercholesterolemia; Immunohistochemistry; Kidney; Kidney Cortex; Lipid Peroxidation; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Oxidation-Reduction; Probucol; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Vitamin E	1997
Failure of antioxidant therapy to attenuate interstitial disease in rats with reversible nephrotic syndrome. Journal of the American Society of Nephrology : JASN, 1998, Volume: 9, Issue:2 Topics: Animals; Anticholesteremic Agents; Antioxidants; Cholesterol; Collagen; Female; Fibronectins; Fibrosis; Kidney; Lipid Peroxides; Lipoproteins, LDL; Liver; Lovastatin; Macrophages; Microscopy, Fluorescence; Nephrotic Syndrome; Organ Size; Probucol; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Time Factors; Transforming Growth Factor beta; Treatment Failure; Vitamin E	1998